Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,897 | 323 | 98.8% |
| Education | $53.47 | 5 | 1.1% |
| Entertainment | $5.70 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,490 | 118 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $414.32 | 32 | $0 (2022) |
| Janssen Biotech, Inc. | $230.08 | 15 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $224.37 | 17 | $0 (2022) |
| Gilead Sciences, Inc. | $218.21 | 13 | $0 (2022) |
| Daiichi Sankyo Inc. | $200.91 | 9 | $0 (2022) |
| Merck Sharp & Dohme LLC | $190.78 | 12 | $0 (2023) |
| QOL Medical, LLC | $165.54 | 15 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $146.29 | 6 | $0 (2017) |
| RedHill Biopharma Inc. | $136.00 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $548.73 | 23 | ABBVIE INC. ($380.19) |
| 2023 | $322.16 | 24 | ABBVIE INC. ($143.82) |
| 2022 | $505.80 | 37 | ABBVIE INC. ($221.67) |
| 2021 | $499.91 | 25 | RedHill Biopharma Inc. ($119.92) |
| 2020 | $350.18 | 16 | Janssen Scientific Affairs, LLC ($125.00) |
| 2019 | $911.57 | 66 | AbbVie, Inc. ($291.97) |
| 2018 | $779.89 | 70 | AbbVie, Inc. ($191.81) |
| 2017 | $1,038 | 68 | Valeant Pharmaceuticals North America LLC ($146.29) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $117.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $16.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/14/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Gastrointestinal AI | ||||||
| 03/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $116.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: VIROLOGY | ||||||
| 01/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/09/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $15.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,616 | 1,722 | $1.1M | $186,110 |
| 2022 | 18 | 1,878 | 1,975 | $1.1M | $219,115 |
| 2021 | 18 | 1,586 | 1,698 | $931,519 | $179,698 |
| 2020 | 18 | 1,514 | 1,631 | $901,124 | $159,351 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 232 | 232 | $344,288 | $50,251 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 363 | $64,977 | $35,532 | 54.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 143 | 143 | $42,900 | $17,841 | 41.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 160 | 160 | $203,520 | $14,376 | 7.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 196 | 201 | $144,720 | $12,581 | 8.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 58 | 59 | $62,540 | $11,155 | 17.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 57 | 57 | $60,420 | $10,877 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 74 | $19,610 | $10,519 | 53.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $11,330 | $4,611 | 40.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 30 | $10,890 | $4,399 | 40.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 34 | 34 | $21,624 | $3,381 | 15.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $6,426 | $2,828 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 40 | $4,640 | $2,803 | 60.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $21,200 | $2,779 | 13.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $10,176 | $1,014 | 10.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 197 | 197 | $9,850 | $652.87 | 6.6% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 13 | 13 | $1,625 | $357.76 | 22.0% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $13,992 | $151.55 | 1.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 205 | 205 | $304,220 | $42,864 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 372 | $66,588 | $37,376 | 56.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 190 | 190 | $57,000 | $24,158 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 107 | 119 | $31,535 | $16,262 | 51.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 164 | 164 | $208,608 | $14,121 | 6.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 82 | 83 | $30,129 | $12,758 | 42.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 60 | 61 | $64,660 | $11,578 | 17.9% |
About Dr. Richard Hell, M.D
Dr. Richard Hell, M.D is a Gastroenterology healthcare provider based in Monterey, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114937927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Hell, M.D has received a total of $4,956 in payments from pharmaceutical and medical device companies, with $548.73 received in 2024. These payments were reported across 329 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,897).
As a Medicare-enrolled provider, Hell has provided services to 6,594 Medicare beneficiaries, totaling 7,026 services with total Medicare billing of $744,274. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Monterey, CA
- Active Since 08/08/2006
- Last Updated 12/18/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1114937927
Products in Payments
- XIFAXAN (Drug) $381.04
- SKYRIZI (Biological) $332.46
- STELARA (Biological) $253.44
- Humira (Biological) $239.30
- Creon (Drug) $229.14
- Entyvio (Biological) $198.17
- HUMIRA (Biological) $186.27
- RINVOQ (Biological) $179.30
- Sucraid (Drug) $152.18
- Mavyret (Drug) $143.59
- Talicia (Drug) $136.00
- Trulance (Drug) $131.42
- Movantik (Drug) $116.61
- LINZESS (Drug) $105.71
- DIFICID (Drug) $93.91
- Linzess (Drug) $84.57
- INJECTAFER (Drug) $84.30
- Vemlidy (Drug) $81.94
- OCALIVA (Drug) $81.90
- ZEPOSIA (Drug) $81.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Monterey
Jan Kamler, Md, MD
Gastroenterology — Payments: $265,773
Dr. Kathryn Swanson, M.d, M.D
Gastroenterology — Payments: $6,109
Dr. Toby Katz, M.d, M.D
Gastroenterology — Payments: $3,517
Steve Hu
Gastroenterology — Payments: $2,533
Dr. Lloyd Garren, M.d, M.D
Gastroenterology — Payments: $988.61
Dr. Michael Smith, M.d, M.D
Gastroenterology — Payments: $327.19